Transforming Medicine
with Proven Products

Heart Failure Diuresis –
Where and When Needed

Our advanced precision pump technology enables cost-effective subcutaneous administration
of pharmaceuticals.

Taking the PICC
out of OPAT

Our convenient sc2Wear™ Infusor enables subcutaneous anytime anywhere delivery of drugs
that now require intravenous or intramuscular administration.

We are a pharmaceutical company developing a new and better way to administer some of the most important drugs used in medicine.

Heart Failure

Improving heart failure outcomes with the subcutaneous administration of furosemide.

Infectious Disease

Revolutionizing outpatient parenteral antibiotic therapy treatment by means of subcutaneous delivery.

Why scPharmaceuticals

Changing the Heart Failure Treatment Paradigm with the sc2Wear™ Infusor

scPharmaceuticals - working to enable better care for less through the subcutaneous administration of proven pharmaceuticals.

Learn More

News

Go to News & Events
10/31/16

scPharmaceuticals Announces Presentation on Subcutaneous Ceftriaxone at IDWeek 2016

FOR IMMEDIATE RELEASE: Lexington, MA., October 31, 2016 /PRNewswire/ — scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery, announced today the presentation of study results at IDWeek 2016 in New Orleans, Louisiana.

9/21/16

scPharmaceuticals in the News: MD Magazine Interviews Pieter Muntendam

On September 19, 2016, as part of their HFSA2016 Conference coverage, MD Magazine publishes “Interview with Pieter Muntendam: Reducing Patients’ Hospital Stay,” a video interview.

9/21/16

scPharmaceuticals in the News: MD Magazine Article

On September 19, 2016, MD Magazine publishes article, “Novel Buffered Subcutaneous Furosemide Combines Lower Cost and Therapeutic Benefit for Patients with Heart Failure,” highlighting scPharmaceuticals' 2016 HFSA presentation on how subcutaneous furosemide use may offer a convenient, lower-cost alternative to intravenous (IV) furosemide for heart failure diuresis.